Randomized controlled clinical trial comparing one-piece and two-piece dental implants supporting fixed and removable dental prostheses: 4- to 6-year observations by Gamper, Felix B et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2017
Randomized controlled clinical trial comparing one-piece and two-piece
dental implants supporting fixed and removable dental prostheses: 4- to
6-year observations
Gamper, Felix B; Benic, Goran I; Sanz-Martin, Ignacio; Asgeirsson, Asgeir G; Hämmerle, Christoph H
F; Thoma, Daniel S
Abstract: OBJECTIVES To test whether or not a one- (S1) and a two-piece (S2) dental implant systems
render the same biological, technical, and esthetic outcomes regarding implants and implant-supported
reconstructions over an observation period of 4 to 6 years. MATERIALS AND METHODS Sixty patients
were randomly assigned to receive S1 or S2 implants. The implants were restored with either fixed or
removable prostheses. The insertion of the final reconstruction was chosen as baseline. One-year and
4- to 6-year (FU-5) measurements included biological (e.g. marginal bone level, probing pocket depth,
peri-implant mucositis, and peri-implantitis), technical (e.g. fracture or loosening of prosthetic screws,
fracture or loosening of abutments, fracture of framework, and/or veneering ceramic (minor, major),
loss of retention for cemented restorations), and esthetic parameters (visibility of the crown margin,
shimmering of the implant through the mucosa, the level of the facial margo mucosae compared to the
contralateral tooth or implant site and the modified papilla index) for implants and reconstructions.
Survival and success rates of implants and reconstructions were calculated. Because of the asymmetric
data distributions, nonparametric statistical methods were applied. RESULTS The implant-based anal-
ysis revealed a cumulative implant survival rate of 97.9% (S1: 96.6%; S2: 98.9%) at FU-5. The median
marginal bone level for group S1 changed from 0.51 mm at baseline to 0.49 mm at FU-5 and for group S2
from 1.02 mm to 1.35 mm (P < 0.001). Patient-level analyses demonstrated a frequency of peri-implant
mucositis of 7.7% (S1) and 10.0% (S2) and for peri-implantitis of 7.7% (S1) and 13.3% (S2) at FU-5. The
patient-based cumulative implant survival rate was 94.6% (S1: 92.3%; S2: 96.7%). The overall patient-
based biological complication rate amounted to 15.4% (S1) and to 23.3% (S2) (P = 0.517), whereas the
overall technical complication rates were 30.8% (S1) and 13.3% (S2) (P = 0.349). The prosthetic survival
rates were 93.1% for S1 and 100% for S2 (P > 0.05). CONCLUSIONS Both implant systems reveal high
survival rates on the implant and prosthetic level. Apart from marginal bone-level changes, biological
and technical outcomes did not reveal significant differences between the two implant systems.
DOI: https://doi.org/10.1111/clr.13025
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-139614
Journal Article
Accepted Version
Originally published at:
Gamper, Felix B; Benic, Goran I; Sanz-Martin, Ignacio; Asgeirsson, Asgeir G; Hämmerle, Christoph
H F; Thoma, Daniel S (2017). Randomized controlled clinical trial comparing one-piece and two-piece
dental implants supporting fixed and removable dental prostheses: 4- to 6-year observations. Clinical
Oral Implants Research, 28(12):1553-1559.
DOI: https://doi.org/10.1111/clr.13025
2
 Randomized controlled clinical trial comparing one-piece and 
two-piece dental implants supporting fixed and removable 
dental prostheses: 4- to 6-year observations 
 
Felix B. Gamper1, Goran I. Benic1, Ignacio Sanz Martin2, Asgeir G. Asgeirsson1,3, Christoph H. 
F. Hämmerle1, Daniel S. Thoma1 
 
1 Clinic of Fixed and Removable Prosthodontics and Dental Material Science, Center for Dental 
Medicine, University of Zurich, Zurich, Switzerland 
2 Section of Periodontology, Faculty of Odontology, University Complutense of Madrid, Madrid, 
Spain 
3 University of Iceland, Faculty of Odontology, Reykjavik, Iceland 
 
Key words:  “dental implants”, “humans”, “crown”, “fixed, partial, denture”, “removable 
denture”, “survival”, “radiographic”, “longterm”, “complications”, “comparison” 
 
Running title: long-term study comparing two implant systems 
Number of figures: 0 
Number of tables: 4 
Word count: 4'200 
 
Address for correspondence:  PD Dr. Daniel S. Thoma 
Clinic of Fixed and Removable Prosthodontics and Dental 
Material Science 
Center of Dental Medicine, University of Zurich  
 Plattenstrasse 11 
 CH-8032 Zurich, Switzerland 
 Phone: +41 1 634 32 52 
 Fax: +41 1 634 43 05 
 e-mail: daniel.thoma@zzm.uzh.ch 
 Abstract 
Objectives: To test whether or not a one- (S1) and a two-piece (S2) dental implant system 
render the same biological, technical and esthetic outcomes regarding implants and implant-
supported reconstructions over an observation period of 4 to 6 years. 
Materials and methods: Sixty patients were randomly assigned to receive S1 or S2 im-
plants. The implants were restored with either fixed or removable prostheses. The insertion of 
the final reconstruction was chosen as baseline. One-year and 4- to 6-year (FU-5) measure-
ments included biological (e.g. marginal bone level, probing pocket depth, peri-implant mu-
cositis and peri-implantitis), technical (e.g. fracture or loosening of prosthetic screws, fracture 
or loosening of abutments, fracture of framework and/or veneering ceramic (minor, major), 
loss of retention for cemented restorations) and esthetic parameters (visibility of the crown 
margin, shimmering of the implant through the mucosa, the level of the facial margo mucosae 
compared to the contralateral tooth or implant site and the modified papilla index) for implants 
and reconstructions. Survival and success rates of implants and reconstructions were calculat-
ed. Because of the asymmetric data distributions, nonparametric statistical methods were ap-
plied. 
Results: The implant-based analysis revealed a cumulative implant survival rate of 97.9% 
(S1: 96.6%; S2: 98.9%) at FU-5. The median marginal bone level for group S1 changed from 
0.51mm at baseline to 0.49mm at FU-5 and for group S2 from 1.02mm to 1.35mm (p<0.001). 
Patient-level analyses demonstrated a frequency of peri-implant mucositis of 7.7% (S1) and 
10.0% (S2) and for peri-implantitis of 7.7% (S1) and 13.3% (S2) at FU-5. The patient-based 
cumulative implant survival rate was 94.6% (S1: 92.3%; S2: 96.7%). The overall patient-
based biological complication rate amounted to 15.4 % (S1) and to 23.3% (S2) (p=0.517), 
whereas the overall technical complication rates were 30.8% (S1) and 13.3% (S2) (p=0.349). 
The prosthetic survival rates were 93.1% for S1 and 100% for S2 (p>0.05).  
Conclusions: Both implant systems reveal high survival rates on the implant and prosthetic 
level. Apart from marginal bone level changes, biological and technical outcomes did not re-
veal significant differences between the two implant systems.  
 Introduction 
The use of dental implants is considered a predictable therapeutic option for the rehabilitation 
of partially or fully edentulous patients providing long-term function and esthetics (Chappuis et 
al. 2013; Jung et al. 2012; Pjetursson et al. 2012b). The indication spectrum includes various 
prosthetic reconstructions of either fixed or removable nature. Since their development in the 
early 1970s (Adell et al. 1970; Branemark et al. 1969a; Branemark et al. 1971; Schroeder et 
al. 1976; Schroeder et al. 1978) the promising long-term data of dental implants (Adell et al. 
1981; Branemark et al. 1977a; Buser et al. 1997; Merickse-Stern et al. 2001) resulted in an 
increasing number of implant systems with different designs and surfaces on the market. In 
general, two main types of dental implant designs are distinguished: one-piece and two-piece 
implants. One-piece implants are characterized by a rough body for intraosseous placment and 
a machined collar, the latter part ermerging through the soft tissues (Scacchi 2000; Scacchi et 
al. 2000). Two-piece dental implants were originally designed for submerged healing. Sub-
merging appears to reduce initial bone resorption after implant placement (Ericsson et al. 
1996; Ericsson et al. 1994). A second surgical intervention (abutment connection) (Branemark 
et al. 1969b; Branemark et al. 1977b) then becomes necessary, however, to connect the pros-
thesis to the implant. Following this second-stage procedure, remodeling of the marginal bone 
takes place (Belser et al. 1998; Esposito et al. 1993; Tarnow et al. 2003). Both types of im-
plants have been used for years and long-term data demonstrate high survival rates (Derks et 
al. 2015). Apart from survival rates, the number of complications on the implant and the pros-
thetic level is of high interest for both clinicians and patients alike. In systematic reviews (Jung 
et al. 2012; Pjetursson et al. 2012b) complication rates have been shown in a range of 3.5-
8.8% (technical), 2.6-8.5% (biological) and 3.6-13-6% (esthetic). Today, it is unknown 
whether the general design differences between one- and two-piece dental implants affect the 
long-term rates of technical, biological and esthetic complications. There are few clinical stud-
ies comparing different implant systems, such as one- versus two-piece implants (Astrand et 
al. 1999; Meijer et al. 2004; Moberg et al. 2001; Pinholt 2003; Thoma et al. 2014). Moreover, 
the literature is scarce in terms of randomized controlled clinical trials (RCTs) comparing dif-
ferent implant systems (Esposito et al. 2005). In a systematic review, only four RCTs fulfilled 
 the inclusion criteria and reported on a total of 204 patients. It was concluded that there is no 
strong evidence supporting the superiority of one implant system over others. It is important 
to note that this review was based on a few RCTs, evaluating few implant systems in few pa-
tients. Hence, a clear need was stated for more long-term studies comparing different implant 
systems. 
The aim of the present clinical trial was, therefore, to test whether or not a one- (S1) and a 
two-piece (S2) dental implant system render the same biological, technical and esthetic out-
comes regarding implants and implant-supported reconstructions over an observation period of 
4 to 6 years. 
 Materials and methods 
The study was designed as a randomized controlled clinical trial and approved by the local eth-
ical committee as a long-term non-interventional study (KEK-ZH-Nr 2014-0201). The specific 
protocol and inclusion criteria were described in a previous publication (Thoma et al. 2014). In 
brief, sixty partially or fully edentulous patients (S1: 13 males and 17 females; S2: 10 males 
and 20 females) in need of implant therapy were consecutively included and randomly allocat-
ed to one of the two groups using a computer-generated randomization list. Exclusion criteria 
were general contraindications for implant therapy (systemic or local diseases) and patients 
not fulfilling the inclusion criteria (medically healthy and older than 18 years). Patients signed 
an informed consent and were, according to a computer-generated list, randomly assigned to 
receive one-piece (Straumann Tissue Level Implants, Institut Straumann, Basel, Switzerland; 
S1) or two-piece dental implants (Brånemark MkIII or MkIV, Nobel Biocare, Zurich, Switzer-
land; S2). All implant surgeries were performed according to the manufacturer’s guidelines. S1 
implants were placed with the transition between the rough and smooth surface at the bone 
crest and S2 implants with the flat top at the bone crest. Some implants were placed with in-
creased sink depth below the bone crest if necessary for prosthetic reasons. The majority of 
the implants in both groups received a bone augmentation procedure (Details in Table 1). Sub-
sequently, implants were subjected to a submerged or transmucosal healing irrespective of the 
implant design (one- or two-piece implant). The type of healing was dependent on the location 
and whether or not bone augmentation procedures were performed.  
Baseline and follow-up examinations 
The insertion of the final reconstruction (between 2004 and 2008) was chosen as baseline and 
patients were subsequently enrolled in an individually designed maintenance program with 
periodic visits to the dental hygienist. The dental hygiene sessions were performed either at 
the Clinic of Fixed and Removable Prosthodontics and Dental Material Science, University of 
Zurich, Switzerland or in private practices. At baseline, the mean age for patients with S1 was 
47.5 years (standard deviation (SD) ± 15) and 55.8 years (± 14) for the S2 group. All 151 
implants (S1: 65; S2: 86) were inserted between 2002 and 2005. A total of 14 patients re-
ported smoking habits: 9 patients in the S1 group (2 patient <5 cigs/day; 7 patients >5 
 cigs/day) and 5 patients in the S2 group (1 patient <5 cigs/day; 4 patients >5 cigs/day). Only 
three patients (1 in S1, 2 in S2) reported habits of bruxism. The differences with regards to 
smoking and bruxism were not significant between the two groups (Thoma et al. 2014). Im-
plant length and implant diameter were recorded and no significant differences were found 
between the two groups (p=0.157, p=0.144 respectively). 
All sixty patients, however, were recalled for the follow-up examinations at one year and again 
at 4 to 6 years (FU-5) following the insertion of the final reconstruction at the Clinic of Fixed 
and Removable Prosthodontics and Dental Material Science, University of Zurich, Switzerland.  
Outcome measures 
The following biological, technical and esthetic parameters were assessed at baseline, one year 
and at 4 to 6 years: 
Biological outcome measures: A full-mouth periodontal status was recorded in each patient. 
This included probing pocket depth (PPD) (Ramfjord 1974), clinical attachment level (CAL), 
plaque control record (PCR) (O'Leary et al. 1972), and bleeding on probing (BOP) (Ainamo & 
Bay 1975). All measurements were recorded at 6 sites per tooth and implant using a UNC-15 
periodontal probe (Hu-Friedy, Chicago, IL, USA). In addition, the width of the keratinized mu-
cosa was measured at the buccal aspect of all implants. Intraoral radiographs were taken using 
a paralleling technique with standardized rim-holders and analog films (Kodak Ektaspeed Plus, 
Eastman Kodak Co., Rochester, NY, USA). After digital scanning of the x-rays, x-rays taken at 
the different time points of assessment were compared and changes of the marginal bone level 
over time were calculated using an open-source software (Image J, National Institutes of 
Health, Bethesda, Maryland USA) For calibration purposes the distance between two implant 
threads and the determination of the exact magnification of the images was used. The refer-
ence point of the two-piece implant (S2) was the most coronal point of the flat top of the im-
plant. At the one-piece implant (S1), the implant shoulder served as reference point for the 
measurements. The marginal bone level was assessed at the mesial and distal implant surfac-
es by measuring the distance from the reference point of the implant to the first bone-to-
implant contact (fBIC). For S1 implants, the expected bone level was at the transition between 
the rough and smooth surface. Therefore, 1.8mm (height of smooth collar) was deducted from 
 all fBIC values. For S2 implants, the bone level was expected at the flat top. No correction of 
fBIC values was therefore performed for S2 implants (Astrand et al. 2002). 
In addition, the incidence of biological complications was documented in the patient records 
and at the follow-up examinations. This included: peri-implant mucositis (clinical signs of in-
flammation without crestal bone loss, probing pocket depth ≥ 5mm and bleeding on probing at 
>50% of the sites at a given implant) and peri-implantitis (mucositis in conjunction with 
crestal bone loss ≥2mm). (Mombelli & Lang 1994)  
Technical outcome measures: All technical complications such as implant fracture, fracture or 
loosening of prosthetic screws, fracture or loosening of abutments, fracture of framework 
and/or veneering ceramic (minor, major), loss of retention for cemented restorations or loos-
ening of screw access hole restorations were continuously documented in the patient records 
and at the follow-up examinations.  
Esthetic and further outcome measures: The following additional parameters were recorded: 
visibility of the crown margin (yes or no), shimmering of the implant through the mucosa (yes 
or no), the level of the peri-implant margo mucosae compared to the contralateral tooth or 
implant site (similar, positive/negative (margo of implant site more coronal/apical) than con-
tralateral site), and the modified papilla index (Jemt 1997). 
Moreover, biological and technical complications as well as survival rates of implants and re-
constructions were calculated at FU-5. Survival was defined as remaining in situ and in func-
tion regardless of therapeutical interventions during the observation period.  
Statistical analysis:  
All data were recorded in Microsoft Excel spreadsheets (Microsoft Corporation, Redmond, WA, 
USA). For the descriptive part of the paper median, quartiles, mean and standard deviation 
were computed on implant-based data. Due to the fact that the generated data were asym-
metric and showed statistical outliers, the authors decided to report medians with quartiles in 
the text. Because of the same reasons, nonparametric mixed models were used for the pa-
tient-level analysis. The rates were compared with Fisher exact test and the corresponding 
95% confidence intervals were derived using the Binomial distribution. Data were analyzed 
 with SAS 9.4 (SAS Institute Inc., Cary, NC, USA). 
 Results 
Demographic data: 
Originally, 60 patients were treated with 151 dental implants. The prosthetic reconstructions 
were removable (17 of the implants), screw-retained (103 of the implants) or cemented (31 of 
the implants). In total, a number of 93 fixed and 6 removable prostheses were placed. A de-
tailed overview of the prosthetic reconstructions are reported in Table 1. The overall mean im-
plant length was 11.2mm (S1: 11.5 ± 1.7mm; S2: 10.7 ± 1.6mm), whereas the mean implant 
diameter was 4.1mm (S1: 4.0 ± 0.3mm, S2: 4.2 ± 0.0mm). Details related to the distribution 
of the implants in the oral cavity are listed in a previous publication (Thoma et al. 2014).  
The median follow-up time was 5.0 years (Q1: 4.7; Q3: 5.2; range 4.2 – 6.4 years) and the 
mean age of the patients 52.7 years (± 15) for group S1 and 60.8 years (± 14) for group S2. 
One male patient and three female patients with a total number of 6 implants (all in group S1) 
were recorded as drop-outs (6.7%). The reasons for the drop-out were due to a cancer-
induced resection of the whole upper jaw (1 patient; 2 implants; cement-retained cantilevered 
splinted single crowns; S1), inability to travel to the study clinic due to patient’s relocation (1 
patient; 2 implants; cement-retained splinted single crowns; S1) or failure to contact the pa-
tients (2 patients; 2 implants; screw-retained single crowns; S1) (Table 1). 
Survival rates: 
During the observation period a total number of three implants were lost. All of them had to be 
explanted because of progressive bone-loss and peri-implant disease, two SCs in group S1 (in 
two different patients), one two-unit FDP on two implants (2FDP) in group S2. Overall, the 
cumulative implant-based survival rate was therefore 97.9% (142 out of 145 implants) at FU-
5. Splitting the two groups, the survival rates changed to 96.6% (57/59 implants) for S1 and 
98.9% (85/86 implants) for S2.  
On the patient-level, the overall cumulative implant survival rate was 94.6% (53/56) at FU-5. 
Calculated for group S1 (24/26), the survival rate was 92.3% (95% c.i. (77%, 99%)) and 
96.7% (95% c.i. (84%, 99.9%)) for group S2 (29/30). The survival rates of S1 and S2 did not 
differ significantly (p=0.592). 
 Radiographic outcomes: 
On the implant level, the median marginal bone level at baseline was 0.51mm (Quartiles (Q): 
0.14;0.96) for S1 and 1.02mm (Q: 0.82;1.23) for S2. At FU-5, the median marginal bone level 
was 0.49mm (Q: 0.16;0.93) for S1 and 1.35mm (Q: 1.12;1.63) for S2 (Table 2A). The inter-
group patient based analysis (S1 vs. S2) revealed no significant differences in terms of mar-
ginal bone levels at baseline (p=0.0722) and significant differences in favor of group S1 at FU-
5 (p=0.0014) (Table 2B). The intra-group patient-based analysis revealed statistically signifi-
cant differences of the marginal bone-level changes between baseline and FU-5 for group S2 
(p=0.0002), but not for group S1 (p=1.00) (Table 2C). The inter-group comparison for chang-
es between baseline and FU-5 was statistically significantly different between S1 and S2 
(p<0.001).  
Biological outcomes: 
Except for peri-implantitis, all parameters measured (PPD, PCR, BOP and the width of the ke-
ratinized mucosa) were similar for both groups and at both time-points (Table 3). Over the 
observation period, the number of implants diagnosed with peri-implant mucositis was 3/57 
(5.3%) in 2 patients for S1 and 9/85 (10.6%) in 3 patients for S2. Six out of 9 implants diag-
nosed with peri-implant mucositis in group S2 were in the same patient, treated with a bar-
retained hybrid prosthesis. On the patient-level, the rate for peri-implant mucositis was 7.7% 
(95% c.i. (1%, 23%)) for group S1 (2/26) and 10.0% (95% c.i.(3%, 25%)) for group S2 
(3/30) up to FU-5. These rates between the two groups did not differ significantly (p=1.00).  
The number of implants affected by peri-implant disease was 4/57 (7.0%) for S1 and 7/86 
(8.1%) for S2. In group S1, only two patients were affected (one patient, two implants; one 
patient, two implants). In group S2 and 7 implants in four patients were diagnosed with peri-
implantitis (one patient, one implant; one patient, one implant; one patient, two implants; one 
patient, three implants). These implants showing progressive bone loss and were treated ac-
cording to a standard protocols both non-surgically and surgically. On the level of the patient, 
the cumulative rate for peri-implantitis was 10.7% (6/56), 7.7% (95% c.i. (1%, 23%)) for 
group S1 (2/26) and 13.3% (95% c.i. (5%, 29%)) for group S2 (4/30) (p=0.675) at FU-5.  
 The patient-based analysis revealed a total biological complication rate of 19.6% (11/56), re-
sulting in 15.4 % (95% c.i. (5%, 33%)) for S1 (4/26) and in 23.3% (95% c.i. (10%, 41%)) 
for S2 (7/30) (p=0.517).  
Technical outcomes:  
During a median observation period of 5 years, 23 out of 145 implants demonstrated a total 
number of 30 technical complications. Twenty-two of the 27 affected implants were in group 
S1 showing 83.3% (25/30) of all technical complications in the present study. This included for 
group S1: 8 matrices having been renewed (2/8 in the same patient/same implant; 5/8 in the 
same patient on 5 different implants; 1/8 in one patient, one implant), 10 screw loosenings 
(1/10 in one patient, one implant; 2/10 in one patient, one implant; 3/10 in one patient, three 
implants; 4/10 in one patient, four implants), 4 minor chippings (2/4 in one patient, two im-
plants; 2/4 in one patient, two implants) and three times a loss of the screw access hole resto-
rations (in one patient, three implants). The patient-based analysis revealed a total technical 
complication rate of 34.6% (95% c.i. (17.2%, 55.7%)) for S1 (9/26). In group S2, five implants 
showed five technical complications, which resulted in 19.2% (5/26) of all reported complications. 
This included: three minor chippings (2/3 in one patient, two implants; 1/3 in one patient, one im-
plant), 1 major chipping (one patient, one implant) and 1 loss of the screw access hole restoration 
(one patient, one implant). The patient-based analysis revealed a total technical complication rate 
of 13.3% (95% c.i. (5%, 29%)) for S2 (4/30). The patient-based rates of the two groups were not 
significantly different  (p=0.349). 
In both groups, no implant fractures, fractures of the prosthetic screws, fractures of the abut-
ments or fractures of the frameworks occurred. In group S1 two reconstructions had to be re-
newed. One due to a major chipping, one due to the loss of the abutment tooth wearing a 
tooth-implant supported prostheses. 
These findings resulted in a cumulative implant-based survival rate of the prosthetic recon-
structions of 96.6% (140 out of 145 implants), divided in 93.2% (55 out of 59 implants) for S1 
and 98.9% (85 out of 86 implants) for S2.  
 Based on the patient-level the cumulative survival rate of the prosthesis was 96.4% (54/56). 
92.3% (95% c.i. (77%, 99%)) of the reconstructions survived in group S1 (24/26) and 100% 
(95% c.i. (90%, 100%)) survived in group S2 (30/30) (p=0.211).  
Esthetic and further outcome measures:  
In group S1, a modified papilla index with values ≤ 2 was found in 32 implants at 1 year and 
in 24 implants at FU-5 (S2: 37 and 59 implants, respectively). The peri-implant mucosal mar-
gin was located more apical compared to the contralateral tooth site in 22 implants at 1 year 
and in 30 implants at FU-5 (group S1). In group S2, the respective number of implants was 22 
at 1 year and 42 at FU-5. A shimmering of the implant through the mucosa was observed at 6 
and 12 implant sites (at 1 year and at FU-5) in group S1. The respective number of implants in 
group S2 was 12 (1 year) and 28 (FU-5). All details are displayed in Table 4. 
 
 Discussion 
The present RCT comparing two types of implant systems demonstrated: i) high implant and 
prosthetic survival rates without significant differences between the two implant systems up to 
FU-5; ii) significantly higher marginal bone levels (MBL) at FU-5 and non-significant changes of 
MBL from baseline to FU-5 for the one-piece dental implant system; iii) significantly lower 
marginal bone levels (MBL) and significant changes of MBL from baseline to FU-5 for the two-
piece implant system; iv) a lower rate of biological, but a higher rate of technical complications 
for the one-piece compared to the two-piece implant system.  
Within the present study, a high cumulative implant survival rate of 97.9% was recorded. This 
survival rate compares well to the 97.3% implant survival rate at a 3-year follow-up reported 
in another study comparing the same two implant systems (Astrand et al. 2004). In that ran-
domised split-mouth study in the maxilla, two-piece implants (Brånemark Implants, Nobel Bio-
care) were placed on one side and one-piece implants (Straumann Implants, Institut Strau-
mann) on the contralateral side of the residual dentition. The data are further in line with two 
previously published systematic reviews reporting five year survival rates of 95.6% for im-
plants supporting FDPs (Pjetursson et al. 2012b) and 97.2% for implants supporting SCs (Jung 
et al. 2012). 
In addition, a high prosthetic survival rate of 96.6% was found. Two previously published pro-
spective studies evaluating the same two-piece dental implants and the respective FDPs 
showed estimated survival rates of the reconstructions of 96.3% (Ortorp & Jemt 2008) and 
97.0% (Andersson et al. 2003) after observation periods of 5 years. For the one-piece dental 
implant system, two prospective clinical trials reported even slightly increased estimated pros-
thetic survival rates of 97.5% (Bragger et al. 2001) and 98.7% (Behneke et al. 2000) after 
observation periods of 5 years. Based on the two systematic reviews (Jung et al. 2008b; 
Pjetursson et al. 2012b), meta-analyses revealed a survival rate of implant-supported SCs of 
94.5% and of 95.4% for implant-borne FDPs after 5 years in function. In summary, both, im-
plant and prosthetic survival rates in the present study are in agreement with previously pub-
lished prospective studies and systematic reviews.  
 The marginal bone levels and bone level changes represent an indicator of osseointegration 
and biological success of the implant. A bone loss of 1.5 mm in the first year and 0.2 mm in 
every following year has previously been considered acceptable (Albrektsson et al. 1986). 
Thus, a bone loss of 2.3 mm (1.5 + 4 x 0.2 mm) would be considered a success at 5 years of 
loading. With a median bone level of 0.51 mm at baseline and 0.49 mm at FU-5 for group S1 
and 1.02 mm at baseline and 1.35 mm at FU-5 for group S2, the results in both groups 
demonstrated clinically superior results than the hitherto suggested success criteria (Albreks-
son et al. 1986). In the previously mentioned comparative study (Astrand et al. 2004) apply-
ing the same two implant systems, a mean marginal bone level for the one-piece implant of 
1.4mm at baseline and 1.3mm at the 3-year follow-up was reported. For the two-piece implant 
system, the marginal bone level was located 1.8mm from the reference point at both time-
points. The differences observed between the present and the above-mentioned study might 
be due to the reference points chosen. Both studies, however, have in common that marginal 
bone levels demonstrate only minimal changes over time for the one-piece implant system. In 
the present study, the two-piece implants showed more marginal bone loss over time. It has 
previously been reported at the one-year follow-up of the same patient cohort (Thoma et al. 
2014) that this observation might mainly be associated with two-piece implants having been 
placed deeper with respect to the bone crest than the one-piece implants. Similar observa-
tions, with more marginal bone loss due to greater vertical sink depth, were made in preclinical 
and clinical studies (Hammerle et al. 1996; Jung et al. 2008a).  
In terms of further biological complications such as peri-implant mucositis or peri-implantitis, 
the one-piece implant system demonstrated less biological complications than the two-piece 
implant system. Even though, no statistically significant difference was found, group S1 
showed higher percentages of both peri-implant mucositis and peri-implantitis than group S2. 
These data are in contrast to the findings of a previous split-mouth-study (Astrand et al. 
2004). In that study, 9.1% (7/77) of the one-piece dental implants and none of the two-piece 
dental implants were affected by peri-implant disease. One has to bear in mind, however, that 
the scientific evidence is inconsistent regarding less or more biological complications for a spe-
cific implant system. Moreover, there is a lack of standardization in terms of assessing and 
classifying peri-implant diseases. Peri-implantitis was defined as follows in the present study: 
 probing pocket depth (PPD) ≥5 mm, bleeding on probing/suppuration and bone loss of ≥2mm 
(Mombelli & Lang 1994). Peri-implant mucositis was defined as probing pocket depth (PPD) ≥5 
mm, bleeding on probing/suppuration without bone loss (Renvert et al. 2008). The patient-
based peri-implantitis rate found in a study with 70 patients, 165 one-piece implants and a 
mean follow-up rate of 7.9 years, was 17.1% (Pjetursson et al. 2012a). In one of the most 
recent, large scale clinical analysis, 588 patients having diverse implant systems were investi-
gated 9 years after implant therapy. The reported patient-based prevalence of moder-
ate/severe peri-implantitis was 14.5%. In terms of the odds ratios for moderate/severe peri-
implantitis, significantly higher incidences for patients provided with two-piece implants were 
observed compared to patients provided with one-piece dental implants (Derks et al. 2016). 
The two implant systems differed in the extent of technical complications encountered for the 
fixed and removable reconstructions. Eighty-three percent of all technical complications were 
found in group S1, mainly including renewal of the matrices (removable prostheses) and 
screw-loosening of the fixed reconstructions. Taking into account the limited number of re-
movable prostheses (n=5) and the fact that all complications related to those types of recon-
structions affected only three different patients (and 45.5% of the complications even the 
same implant), these findings have to be interpreted with caution. A comparative randomized 
study including the same two implant systems for the treatment of mandibular edentulism with 
full-arch bridges revealed more need for adjustments in the one-piece implant group during 
the 3-year follow-up period (Moberg et al. 2001). This is in line with the outcomes of the pre-
sent study. Another prospective randomized study comparing one- and two-piece dental im-
plants to support mandibular overdentures revealed no significant differences in the prosthetic 
aftercare over a follow-up period of 5 and even over 10 years (Meijer et al. 2004; Meijer et al. 
2009). The minimal number of removable implant-supported dentures, however, in the pre-
sent study does not allow drawing any conclusions. The frequency of screw-loosening have 
been reported to be 8.8% for single crowns (Jung et al. 2012) and 5.3% for multi-unit recon-
structions (Pjetursson et al. 2012b). One might speculate that the relatively high rate of 
screw-loosenings (15.3% for group S1 and 0.0% for group S2 resulting in an overall rate of 
6.2%) was associated with the use of an intermediate abutment (for the one-piece implant 
system). In all fixed reconstructions, this intermediate abutment was connected to the implant 
 and the final reconstruction then screwed on top with a much lower torque. A retrospective 
analysis of the same one-piece implant system and intermediate abutments used for single-
tooth components found an 8.7% incidence rate of occlusal screw loosening at 6 months 
(Levine et al. 1997). Interestingly, the same research group reported a massive increase of 
occlusal screw loosening up to 22.2% after 2 or more years in function (Levine et al. 1999). 
In daily practice, clinicians normally have to choose one implant system, which they will then 
use for all indications, patients and sites. The outcomes of the present study reflect that both 
implant systems can be used for fixed and removable reconstructions, for a variety of indica-
tions, in partially and fully edentulous patients, for single crowns and multi-unit reconstruc-
tions. Survival and complications rates were well within the magnitude of other clinical trials 
using often more strict inclusion criteria and highly limited indications. From a strictly scientific 
point of view, the information derived from the present RCT comparing two implant systems 
must, however, be interprented with caution due to the asymmetric distribution of the im-
plants and the heterogeneity of the reconstructions. 
 
 Conclusions 
Both implant systems reveal high survival rates on the implant and prosthetic level over an 
observation period of 4-6 years without significant differences between the two groups. Apart 
from marginal bone level changes (in favor of the one-piece implant system), biological, and 
technical outcomes did not reveal significant differences.  
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 Tables legend 
Table 1: Type of augmentation and type of reconstructions on the implant level for both sys-
tems, S1= one-piece (Straumann Tissue Level Implants, Institut Straumann, Basel, Switzer-
land) and S2= two-piece dental implants (Brånemark MkIII or MkIV, Nobel Biocare, Zurich, 
Switzerland); guided bone regeneration (GBR), some implants received both primary and sim-
ultaneous augmentation procedures; single crowns (SC), 2-unit cantilevered FDP (2FDP), 
splinted single crowns and implant-borne multi-unit reconstructions without cantilever (FDP), 
cantilevered splinted single crowns and implant-borne multi-unit reconstructions (cFDP), tooth-
implant supported prostheses (TISP's), implant-supported removable dentures (ISRD's). The 
numbers in parentheses display the number of implants. 
 
Table 2: Marginal bone level (MBL) at baseline and at FU-5 and marginal bone level alterations 
between baseline and FU-5. A. Implant-level analysis of MBL at baseline and at FU-5 with 
means, SD's, medians and quartiles. nBL= number of implants at baseline; n5y= number of 
implants at FU-5. B. Patient-level analysis of inter-group comparisons between S1 and S2 at 
baseline and at FU-5; p-values between the groups for each time-point. C. Patient-level analy-
sis of MBL changes over time with means, standard deviations (SD) and p-values within the 
groups. nBL= number of patients at baseline; n5y= number of patients at FU-5; p-values with-
in the groups over time.   
nS1= number of patients in group S1; nS2= number of patients in group S2. S1= one-piece 
(Straumann Tissue Level Implants, Institut Straumann, Basel, Switzerland) and S2= two-piece 
dental implants (Brånemark MkIII or MkIV, Nobel Biocare, Zurich, Switzerland).  
 
Table 3: Clinical parameters for both implant systems (S1 and S2) at baseline and at FU-5. 
Implant-level analysis with with means, standard deviations (SD), medians and quartiles. 
nBL= number of implants at baseline; n5y = number of implants at FU-5. S1= one-piece 
(Straumann Tissue Level Implants, Institut Straumann, Basel, Switzerland) and S2= two-piece 
 dental implants (Brånemark MkIII or MkIV, Nobel Biocare, Zurich, Switzerland). PPD (probing 
pocket depth), PlI (plaque index), BOP (bleeding on probing), KT (keratinized tissue) 
 
Table 4: Esthetic and further outcome measures at one year and at FU-5. S1= one-piece 
(Straumann Tissue Level Implants, Institut Straumann, Basel, Switzerland) and S2= two-piece 
dental implants (Brånemark MkIII or MkIV, Nobel Biocare, Zurich, Switzerland) 
 
 
  
 
 
 Type of augmentation Type of reconstruction and respective number of implants 
 No 
augmen
tation 
Simulta
neous 
GBR 
Primary 
bone 
augmen
tation 
(autoge
nous 
bone 
block) 
Primary 
sinus 
elevatio
n 
Simultan
eous 
sinus 
elevation 
SC 2FDP FDP cFDP TISP's ISRD Total 
S1 11 44 6 4 10 21 (21) 1 (1) 11 (23) 4 (8) 3 (3) 4 (9) 44 (65) 
S2 17 49 6 9 12 25 (25) 2 (2) 20 (42) 2 (5) 4 (4) 2 (8) 55 (86) 
Table 1 
 
 
 
  
  
 
 
(A) 
Variable 
Time 
S1 (nBL= 65; n= 57) S2 (nBL= 86; n5y= 85) 
Mean SD (±) Lower Q Median Upper Q Mean SD (±) Lower Q Median Upper Q 
MBL 
Baseline 0.61mm 0.82mm 0.14mm 0.51mm 0.96mm 1.07mm 0.51mm 0.82mm 1.02mm 1.23mm 
FU-5 0.62mm 0.77mm 0.16mm 0.49mm 0.93mm 1.39mm 0.44mm 1.12mm 1.35mm 1.63mm 
 
(B) Baseline (nS1= 30; nS2= 30) P-Value FU-5 (nS1= 26; nS2= 30) P-Value 
MBL S1 vs. S2 -0.485mm (SD ± 0.171) 0.0722 -0.683mm (SD ± 0.173) 0.0014 
 
(C) S1 (nBL= 30; n5y = 26) P-Value S2 (nBL = 30; n5y= 30) P-Value 
MBL change Baseline - 
FU-5 0.12 mm (SD ± 0.086) 1.000 0.32mm (SD ± 0.0713) 0.0002 
Table 2 
  
 
 
Variable Time 
S1 (nBL= 65; n5y= 57) S2 (nBL= 86; n5y= 85) 
Mean SD (±) Lower Q Median Upper Q Mean SD (±) Lower Q Median Upper Q 
PPD 
Baseline 3.04mm 0.66mm 2.67mm 3.00mm 3.33mm 2.98mm 0.65mm 2.67mm 2.83mm 3.00mm 
FU-5 3.45mm 0.80mm 2.83mm 3.33mm 3.67mm 3.36mm 0.93mm 2.83mm 3.17mm 3.83mm 
PlI 
Baseline 14.5% 26.2% 0% 0% 18.7% 11.9% 19.9% 0% 0% 16.6% 
FU-5 21.0% 30.0% 0% 0% 31.0% 21.0% 28.0% 0% 10% 33.0% 
BOP 
Baseline 30.9% 26.7% 16.6% 21.8% 43.7% 28.0% 22.4% 5.0% 25% 45.8% 
FU-5 41.0% 34.0% 13.0% 25% 75.0% 31.0% 23.0% 15.0% 28% 50.0% 
KT FU-5 1.92mm 1.68mm 0.0mm 2.0mm 3.0mm 1.99mm 1.52mm 1.0mm 2.0mm 3.0mm 
Table 3 
 
 
  
  
 1y 5y 
 S1 S2 S1 S2 
Modified papilla index (Jemt 1997) ≤ 2 32 37 24 59 
Shimmering of the implant through the mucosa 6 12 12 28 
Visibility of the crown margin 17 15 14 19 
Level of the margo mucosae compared to the contralateral site 22 22 30 42 
Table 4 
